Phase 1 Motor Neurone Disease Trial, Recruiting NCT07100119 Sponsor: Eli Lilly and Company Condition: Motor Neurone Disease
Back to Motor Neurone Disease

Phase 1 Motor Neurone Disease Trial, Recruiting

NCT07100119
Recruiting Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with ALS (also known as Lou Gehrig's disease) — as definite, possible, or probable — by a doctor who specializes in managing this condition.
  • Your ALS symptoms started no more than 24 months (2 years) before your screening appointment, as determined by the study doctor.
  • Your Body Mass Index (BMI) — a measure of body weight relative to height — is between 18.0 and 35.0.

Who may not be able to join:

  • You have a history of, or currently have, a significant medical condition affecting the heart, kidneys, liver, stomach or gut, lungs, blood, hormones, mental health, or nervous system, or you have had seizures, or have abnormal results on certain medical tests.
  • You have been diagnosed with another disease that affects the brain or nervous system over time, or you have significant memory loss or severe thinking/cognitive problems.
  • Your blood test results show that certain liver-related values (ALT, AST, or total bilirubin) are more than twice the normal upper limit.
  • Your kidneys are not functioning well enough, based on a specific measure of kidney filtering ability falling below a certain level (confirm with trial site).
  • Your heart's electrical activity, measured by a specific heart tracing test (ECG) done at screening, shows abnormalities that the study doctor believes could make participation risky.
  • You have significant abnormalities in your lower spine, either known beforehand or found during screening X-rays or imaging scans (if these are performed).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST), Eli Lilly and Company

Phone: 1-317-615-4559

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 1
Registry
ClinicalTrials.gov
Start date
5 August 2025
Est. completion
1 August 2027

Where this trial is recruiting

🇧🇪 Belgium 🇨🇦 Canada 🇩🇪 Germany 🇳🇱 Netherlands 🇪🇸 Spain

Primary endpoints

Number of Participants with One or More Treatment Emergent Adverse Events (TEAEs), Serious Adverse Event(s) (SAEs), and Adverse Event(s) (AEs) Considered by the Investigator to be Related to Study Drug Administration

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov